Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

Similar articles for PubMed (Select 23026185)

1.

C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.

Bewtra AK, Levy RJ, Jacobson KW, Wasserman RL, Machnig T, Craig TJ.

Allergy Asthma Proc. 2012 Sep-Oct;33(5):427-31. doi: 10.2500/aap.2012.33.3597.

PMID:
23026185
2.

Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.

Craig TJ, Bewtra AK, Hurewitz D, Levy R, Janss G, Jacobson KW, Packer F, Bernstein JA, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.

Allergy Asthma Proc. 2012 Jul-Aug;33(4):354-61. doi: 10.2500/aap.2012.33.3589.

PMID:
22856636
3.

Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.

Riedl MA, Hurewitz DS, Levy R, Busse PJ, Fitts D, Kalfus I.

Ann Allergy Asthma Immunol. 2012 Jan;108(1):49-53. doi: 10.1016/j.anai.2011.10.017. Epub 2011 Nov 21.

PMID:
22192966
4.

C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.

Craig TJ, Bewtra AK, Bahna SL, Hurewitz D, Schneider LC, Levy RJ, Moy JN, Offenberger J, Jacobson KW, Yang WH, Eidelman F, Janss G, Packer FR, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.

Allergy. 2011 Dec;66(12):1604-11. doi: 10.1111/j.1398-9995.2011.02702.x. Epub 2011 Sep 2.

PMID:
21884533
5.

Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.

Moldovan D, Reshef A, Fabiani J, Kivity S, Toubi E, Shlesinger M, Triggiani M, Montinaro V, Cillari E, Realdi G, Cancian M, Visscher S, Zanichelli A, Relan A, Cicardi M.

Clin Exp Allergy. 2012 Jun;42(6):929-35. doi: 10.1111/j.1365-2222.2012.03984.x.

PMID:
22909164
6.

Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.

Grant JA, White MV, Li HH, Fitts D, Kalfus IN, Uknis ME, Lumry WR.

Allergy Asthma Proc. 2012 Jul-Aug;33(4):348-53. doi: 10.2500/aap.2012.33.3585.

PMID:
22856635
7.

Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema.

Craig TJ, Wasserman RL, Levy RJ, Bewtra AK, Schneider L, Packer F, Yang WH, Keinecke HO, Kiessling PC.

J Clin Immunol. 2010 Nov;30(6):823-9. doi: 10.1007/s10875-010-9442-1. Epub 2010 Jul 16.

8.

Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.

Craig TJ, Rojavin MA, Machnig T, Keinecke HO, Bernstein JA.

Ann Allergy Asthma Immunol. 2013 Sep;111(3):211-5. doi: 10.1016/j.anai.2013.06.021. Epub 2013 Jul 16.

PMID:
23987198
9.

Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits.

Bygum A, Andersen KE, Mikkelsen CS.

Eur J Dermatol. 2009 Mar-Apr;19(2):147-51. doi: 10.1684/ejd.2008.0603.

PMID:
19264579
10.

Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.

Wasserman RL, Levy RJ, Bewtra AK, Hurewitz D, Craig TJ, Kiessling PC, Keinecke HO, Bernstein JA.

Ann Allergy Asthma Immunol. 2011 Jan;106(1):62-8. doi: 10.1016/j.anai.2010.10.012. Epub 2010 Nov 20.

PMID:
21195947
11.

Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.

Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, von Hentig N, Klingebiel T, Kreuz W.

Transfusion. 2010 Feb;50(2):354-60. doi: 10.1111/j.1537-2995.2009.02394.x. Epub 2009 Sep 24.

PMID:
19788511
12.

Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.

Lyseng-Williamson KA.

BioDrugs. 2011 Oct 1;25(5):317-27. doi: 10.2165/11208390-000000000-00000. Review.

PMID:
21942916
13.

C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.

Schneider L, Hurewitz D, Wasserman R, Obtulowicz K, Machnig T, Moldovan D, Reshef A, Craig TJ.

Pediatr Allergy Immunol. 2013 Feb;24(1):54-60. doi: 10.1111/pai.12024. Epub 2012 Nov 22.

PMID:
23173714
14.

C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.

Kreuz W, Martinez-Saguer I, Aygören-Pürsün E, Rusicke E, Heller C, Klingebiel T.

Transfusion. 2009 Sep;49(9):1987-95. doi: 10.1111/j.1537-2995.2009.02230.x. Epub 2009 May 20.

PMID:
19497056
15.

Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.

Gower RG, Lumry WR, Davis-Lorton MA, Johnston DT, Busse PJ.

Allergy Asthma Proc. 2012 May-Jun;33(3):235-40. doi: 10.2500/aap.2012.33.3573. Review.

PMID:
22584192
16.

Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.

Riedl MA, Lumry WR, Li HH, Craig TJ, Fitts D, Kalfus I, Uknis ME.

Am J Rhinol Allergy. 2013 Nov-Dec;27(6):517-21. doi: 10.2500/ajra.2013.27.3973.

PMID:
24274230
17.

Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.

Lumry W, Manning ME, Hurewitz DS, Davis-Lorton M, Fitts D, Kalfus IN, Uknis ME.

J Pediatr. 2013 May;162(5):1017-22.e1-2. doi: 10.1016/j.jpeds.2012.11.030. Epub 2013 Jan 11.

PMID:
23312695
18.

Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study.

Martinez-Saguer I, Cicardi M, Suffritti C, Rusicke E, Aygören-Pürsün E, Stoll H, Rossmanith T, Feussner A, Kalina U, Kreuz W.

Transfusion. 2014 Jun;54(6):1552-61. doi: 10.1111/trf.12501. Epub 2013 Nov 24.

19.

Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate.

Tallroth GA.

Int Arch Allergy Immunol. 2011;154(4):356-9. doi: 10.1159/000321830. Epub 2010 Oct 26.

PMID:
20975289
20.

Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate.

Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, Heller C, Klingebiel T, Kreuz W.

Am J Obstet Gynecol. 2010 Aug;203(2):131.e1-7. doi: 10.1016/j.ajog.2010.03.003. Epub 2010 May 14.

PMID:
20471627
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk